{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-089805","form_type":"8-K","ticker":"RNAZ","cik":"0001829635","company_name":"Transcode Therapeutics, Inc.","filed_at":"2026-08-03T20:15:50+00:00","discovered_at":"2026-08-03T20:17:01.644490+00:00","generated_at":"2026-08-03T20:17:22.167673+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"TransCode amends preferred stock certificate to remove 60-day notice for ownership limit changes","bullets":["Second Amended and Restated Certificate of Designation filed on August 3, 2026.","Removes 60-day notice requirement to change or waive beneficial ownership limitation.","No other changes to the certificate; no additional securities issued or sold.","Amendment approved by majority of preferred stockholders and Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-089805","json":"https://secwatch.observer/filing/0001104659-26-089805.json","markdown":"https://secwatch.observer/filing/0001104659-26-089805.md","text":"https://secwatch.observer/filing/0001104659-26-089805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/0001104659-26-089805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/tm2622073d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:17:22.167673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}